Related Experiment Videos
A newly established human osteosarcoma cell line with osteoblastic properties.
1Department of Orthopaedic Surgery, Okayama University, Medical School, Japan.
Clinical Orthopaedics and Related Research
|October 1, 1990
Summary
A new human osteosarcoma cell line, HuO9, exhibits osteoblastic characteristics and produces bone gamma-carboxyglutamic acid-containing protein (BGP). This cell line serves as a valuable model for studying osteoblasts and BGP production regulation.
Area of Science:
- Cell Biology
- Biochemistry
- Oncology
Background:
- Osteosarcoma is a primary bone cancer.
- Establishing reliable cell lines is crucial for cancer research.
- Understanding osteoblast function is key to bone biology.
Purpose of the Study:
- To establish and characterize a novel human osteosarcoma cell line.
- To investigate the osteoblastic phenotypes of the HuO9 cell line.
- To evaluate its utility as a model for bone cell research.
Main Methods:
- Establishment of HuO9 cell line from heterotransplanted osteosarcoma.
- Characterization of alkaline phosphatase (ALP) activity and osteocalcin (BGP) secretion.
- In vitro stimulation with 1,25-dihydroxyvitamin D3 and parathyroid hormone.
- Tumorigenicity assessment in nude mice.
Main Results:
- HuO9 cells demonstrated high ALP activity and secreted BGP.
- 1,25-dihydroxyvitamin D3 enhanced ALP activity and BGP secretion.
- Parathyroid hormone stimulated intracellular cAMP production.
- Transplanted HuO9 cells formed osteoid-rich tumors in vivo.
Conclusions:
- The HuO9 cell line exhibits well-differentiated osteoblastic phenotypes.
- HuO9 is the first human cell line established to produce BGP.
- This cell line provides a valuable model for osteoblast research and BGP regulation studies.